Taletrectinib Has "Meaningful Clinical Efficacy" in ROS1+ NSCLC
Taletrectinib can produce durable responses in patients with ROS1-positive non-small cell lung cancer, a phase 2 trial suggests.
Source: cancertherapyadvisor.com
Page 42 - Wei Li News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Wei Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Wei Li Today - Breaking & Trending Today
March Jobs Report: What to Expect
The next jobs report is forecast to reveal a steep slowdown in payrolls growth.
Source: kiplinger.com
Global central banks keep up inflation fight in March
LONDON : The pace of interest rate hikes by major developed and emerging market central banks continued at a healthy clip in March though the scale of rises tapered off somewhat as turmoil in the banking sector clouded the outlook for global growth. March saw six interest rate hikes across eight meetings
Source: channelnewsasia.com
Surviving Inflation: 5 Perfect Dividend Stocks To Get The Job Done
Inflation will remain sticky causing policymakers in the US and EU to prepare the market for more hikes. Read about five dividend stocks to beat inflation when it matters most.
Source: seekingalpha.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZXN3PGUMJ5NT7P6Y2HZ6E2TSKQ.jpg)
Global central banks keep up inflation fight in March
The pace of interest rate hikes by major developed and emerging market central banks continued at a healthy clip in March though the scale of rises tapered off somewhat as turmoil in the banking sector clouded the outlook for global growth.
Source: reuters.com